glad they had good news. I don't see it moving much off that news, both because of timing and because HAE doesn't much move the needle. If they get the analyst upgrades then maybe some movement. Market already expects them to commercialize here. If anything, it will move because it oversold last week. Might get to 5 by the combination of all that, and I would be extremely happy if we got to 6 in next couple of weeks.
Price is being rightfully driven by covid (it's not rare like HAE, demand in the millions, it's on the world radar)
In the long run (years) HAE is a good market despite being rare because it's a chronic condition. Once you get the patient on the drug, you get revenue for years. Looks like over time they will take over that market. This will reflect in their revenue and PPS will go up slowly (again- it's a rare condition).
So I saw this news come in last night and my reaction was meh... figures they'd PR at the worst possible time. Just another example of how they seem incapable of capitalizing on a win, but nothing compared to their fumble of what could have been, potentially still could be, the pandemic winner. Seems like a company with good scientists and bad management.
I really hope you guys are right about hitting 5 or 6 next week. It should already be there now IMO.
AI
Market Data 
Markets 
